The FDA "created a lot of confusion and questions” among doctors and patients by intentionally not following the standard SAE-reporting criteria with an agenda. Ariad felt obligated to stay with the stand. Consequently, the FDA came down hard on Ariad.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.